Dear Sir or Madam,

I am reaching out to express my interest in contributing the data from a scRNA-seq study focused on convalescent COVID-19 patients to the COVID-19 Cell Atlas. Our paper is currently in review, and we would like the dataset to be made publicly available upon publication.

I have reviewed the data format requirements for submission. Before proceeding, I would like to inquire if there are any additional considerations or specific guidelines that I should be aware of to ensure a smooth submission process, or if it really is just the submission of the data itself?

Thank you for your time and assistance!

Kind regards,

Lilly May

---------------------------

Lilly May

Leibniz Institute for Natural Product Research and Infection Biology

– Hans Knöll Institute –

Beutenbergstrasse 11a

07745 Jena

Germany